Table 2.
Correlation between MIR100HG expression and clinicopathological features in hepatocellular carcinoma patients.
| Characteristics | n | MIR100HG | P value | |
|---|---|---|---|---|
| Low (n = 25) | High (n = 25) | |||
| Age | 0.921 | |||
| <50 years | 24 | 11 | 13 | |
| ≥50 years | 26 | 14 | 12 | |
|
| ||||
| Gender | 0.382 | |||
| Male | 29 | 16 | 13 | |
| Females | 21 | 9 | 12 | |
|
| ||||
| Liver cirrhosis | 0.261 | |||
| Yes | 38 | 20 | 18 | |
| No | 12 | 5 | 7 | |
|
| ||||
| Tumor size | 0.428 | |||
| <5 cm | 32 | 18 | 14 | |
| ≥5 cm | 18 | 7 | 11 | |
|
| ||||
| TNM tumor stage | 0.034∗ | |||
| I+II | 28 | 19 | 9 | |
| III+IV | 22 | 6 | 16 | |
|
| ||||
| Edmondson-Steiner grading | 0.046∗ | |||
| I+II | 31 | 21 | 10 | |
| III+IV | 19 | 4 | 15 | |
Note: ∗P < 0.05.